Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen and Genomics Collaborative Announce Joint SNP Analysis Project

NEW YORK, Jan 8 – Qiagen Genomics and Genomics Collaborative have formed a collaboration to compare genetic profiles of patients who have poor reactions to drugs to those with no reported adverse events to metabolic enzymes, the companies announced Monday.

The companies expect to complete the project, in which Qiagen will provide its SNP genotyping services and Genomics Collaborative will offer its database of genetic samples, sometime this spring, the companies said. The companies plan to submit the results of the analysis for publication.

" We believe that drug companies will save costs and reduce the time associated with developing new drugs by having access to patient profiles that can predict individual patient response with regards to drug absorption, distribution, metabolism and excretion outcomes," William Hirschman, GCI's Vice President for Business Development, said in a statement.

The companies said their project is the “most extensive study of its kind ever conducted."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.